[1]
B. Saleem, M. Ishaq, M. Shafique, A. Fawad, and S. Fatima, “INTRAVITREAL TRIAMCINOLONE ALONE VERSUS COMBINED INTRAVITREAL TRIAMCINOLONE AND BEVACIZUMAB ON CENTRAL MACULAR THICKNESS IN DIABETIC MACULAR EDEMA: Triamcinolone Versus Bevacizumab on Central Macular Thickness”, Pak Armed Forces Med J, vol. 66, no. 6, pp. 913–17, Dec. 2016, Accessed: May 14, 2025. [Online]. Available: https://www.pafmj.org/PAFMJ/article/view/1283